Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zishen Yutai Wan (Kidney Nourishing Fetal Pills) is a Traditional Chinese Medicine (TCM) formulation developed by Guangzhou Baiyunshan Zhongyi Pharmaceutical. It is widely used in China for the treatment of threatened miscarriage, recurrent miscarriage, and infertility, particularly as an adjuvant therapy in patients undergoing In Vitro Fertilization (IVF). The formula is composed of multiple herbal ingredients, including *Cuscuta chinensis*, *Dipsacus asper*, and *Panax ginseng*, which are traditionally believed to nourish the kidney and stabilize the fetus. Pharmacological studies suggest that Zishen Yutai Wan improves endometrial receptivity, regulates the hypothalamic-pituitary-ovarian axis, and modulates the immune environment at the maternal-fetal interface to support successful pregnancy outcomes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on zishen yutai wan.